- Bedoelde u
- data comparable
Zoekresultaten - 8 results
Ketamine, a new (or old) kid on the block: A comprehensive three-year spatio-temporal study in Belgium through wastewater-based epidemiology
showed no seasonal trends but an increase in weekend consumption, likely linked to recreational use. PNML s increased 7- to 11-fold compared to available data in 2012. Actual consumption and direct ...
A comparison of COVID-19 incidence rates across six European countries in 2021.
COVID-19 surveillance systems and approaches to reporting in each country. To better understand these differences and their impact on incidence comparisons, we collected data on surveillance systems from six ...
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.
but limited data is available on the immune responses it induces. METHODS: In this observational cohort study, peak humoral and cellular immune responses were compared 28 days after the second and third ...
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: Results of the second data collection (28/09/21-23/02/22)
mRNA vaccine compared to adenoviral-vectored vaccine reduced the risk of being seronegative by 90%. Health Topics: Coronavirus Coronavirus Coronavirus Service: Information sanitaire ...
Closing schools for SARS-CoV-2: a pragmatic rapid recommendation
systematically compared the benefits and harms of closing primary and secondary schools and developed a recommendation. Methods: A multidisciplinary panel, including school pupils and teachers, educational ...
All-cause mortality supports the COVID-19 mortality in Belgium and comparison with major fatal events of the last century.
cases, the number of COVID-19 deaths was compared with the number of deaths from all-cause mortality. Mortality during the COVID-19 pandemic was also compared with historical mortality rates from the last ...
SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data.
compared the performance of SARS-CoV-2 neutralising antibody testing between 12 European laboratories involved in convalescent plasma trials. Raw titres differed almost 100-fold differences between ...
Performance of five rapid serological tests in mild-diseased subjects using finger prick blood for exposure assessment to SARS-CoV-2.
SARS-CoV-2) data. RST-performance for FP blood and serum was assessed by performing each RST in two groups, namely SARSC oV- 2 positive (n=108) and negative healthcare workers (n=89). Differences in accuracy ...